Post by
Finallytherock on Jul 08, 2021 11:18am
Disappointing response by the market
Oh well. Was hoping to get a little bounce
Comment by
fatboy92 on Jul 08, 2021 11:23am
Some people have been waiting for the news to sell their shares. Hopefully that is Beenthere selling at the bid and exiting our lives for good.
Comment by
ronrydell on Jul 08, 2021 11:39am
Suprised to be back at $.38..:(
Comment by
Aarcor on Jul 08, 2021 11:40am
Mice with MS are high-fiving all over the world. Investors....not so much....and it will remain that way until clinical (which is completely out of BTI's control).
Comment by
chrispi on Jul 08, 2021 12:53pm
Sometimes it takes more than 1.5 hours for people to digest the news ;) ... especially during the summer holiday season. But more importantly than the market realizing, or not, the importance and significance of this successful study, is that our current and future partners are now aware of it. That will help licensing negotiations with current and future partners!
Comment by
greaterfoolFred on Jul 08, 2021 2:18pm
chrispi is right. This matters to companies interested in MS, but what everyone else hears is that xb3 works in rodents. Well, we knew that. What will move us is clinical news, or at least news that xb3 works in primates. We have to follow the long term plan; find partners and keep cash in the bank. Our day will come.